Global Human Milk Oligosaccharides (HMO) Market holds potential to reach US$101.6 Mn by 2027, driven by multiple factors, including demand and supply-side drivers.
• Demand Side Drivers:

o Increasing concerns among consumers regarding gut health including bacteria, archaea and fungi are the key drivers resulting market to reach USD XX Mn globally by 2027.
o Europe dominated the Human Milk Oligosaccharides (HMO) Market with a share of 42.18% in the year 2019.
• Supply Side Drivers:

o The market is driven by large players meeting xx% of the demand, which include manufacturers, supplier, and distributors. These players are pushing multiple offerings at different price points.
o Dutch multinational corporation (DSM) would acquire Glycom for $830 million, a Danish company, one of the leading supplier of human milk oligosaccharides (HMOs). With the acquisition, DSM will follow firms like BASF and DuPont, to expand its business presence in the next 5 years.

Global Human Milk Oligosaccharides (HMO) Market
o According to DSM, the global HMO market is currently around US$ 110 million per year and growing rapidly. Glycom reported $80 million in sales in 2019, mostly to Nestlé, which is a large investor in Glycom.

Drivers: Growing consumption of dietary supplements, encourage optimal health and help to prevent certain diseases, help to improve the brain development and enhance memory power, the demand of HMO in infant formula, market players are increasingly investing in the R&D activities, and among others are the key factors resulting the market to grow at a CAGR of 24.1% by 2027.
Rising Demand for HMO in Infant Formula:

The human milk oligosaccharides (HMO) market is poised to receive an upsurge because of useful properties like infection prevention, brain development and memory enhancement in humans, prebiotic effects, and improvement of intestinal health, the demand for HMOs in the design of infant formulas is growing. For instance, in June 2018, Abbott announced its new infant formula product, Similac Eye-Q Plus with human milk oligosaccharides (HMO), in Vietnam.

The addition of HMOs in functional food & beverage products supports the growth of good bacteria and can also eliminate harmful bacteria such as salmonella and campylobacter. The fast-rising health awareness among people in emerging countries like China and India is expected to boost market growth during the forecast period (2020-2027). For instance, in April 2019, Nestle S.A., presented three new products in the U.K., specifically, SMA Advanced Follow-on Formula, SMA Advanced Growing up Milk, and SMA Advanced Infant Formula. These products contained artificial HMOs and were planned for infants who were not breastfed. Such growths within the infant formula sector are expected to drive the demand for human milk oligosaccharides (HMO) in the current future.

Restraint: Lack of technology for large-scale production, high R&D cost, limited production, and stringent government regulations are likely to restrain the HMO market growth.
High Cost of Product Due to Expensive Manufacturing Process:

The low availability of a group of donors, and HMO cannot be produced directly from human milk are the key restraints for the growth of the human milk oligosaccharides (HMO) market. Now, producers are emerging technologies through chemical and enzymatic synthesis to generate human milk oligosaccharides (HMO). These synthetic and enzymatic methods need a high amount of capital and energy, but the production of the final product is comparatively low. For example, for costly substrates like glycosyltransferases, enzymatic synthesis is required and this is one of the main factors due to the high price of oligosaccharides of human milk.
Global Human Milk Oligosaccharides (HMO) Market Opportunities:

The growing concerns among consumers about gut health and the consumption of dietary supplements is expected to generate significant opportunities for the HMO Market. For instance, DuPont Nutrition & Health’s CARE4U is used as a dietary supplement ingredient. The market viewing strong competition because of the increasing number of market entrants. Human milk oligosaccharides (HMOs) act as prebiotics in the human body and support to maintain gut health. They encourage bacterial growth, particularly bifidobacteria genus, in the gut, which helps improve metabolic activity.
Covid-19 Impact on the Human Milk Oligosaccharides (HMO) Market:

• The Covid-19 impact on the market like food production and delivery systems can be disrupted. Recent challenges in food like human milk oligosaccharides (HMO) supply-chain, there is now significant concern about human milk oligosaccharides (HMO) production, processing, distribution, and demand.
• COVID-19 resulted in the movement restrictions of workers, fluctuations in demand of consumers, closure of food production facilities, restricted food trade policies, and financial pressures in the food supply chain. Facilities should change the working conditions and maintain the health and safety of employees by altering safety measures. Food companies face several challenges due to a drop in income, while others are working hard to meet the growing demand of retailers.
Global Human Milk Oligosaccharides (HMO) Market Segment Analysis

By Product, Lacto-N-neotetraose segment accounted for the largest market share in 2019

Lacto-N-neotetraose segment accounted for the largest market share of the global market in 2019. This is mainly due to the increasing growth of useful bifidobacteria and decreasing the growth of pathogenic bacteria which is ultimately appealing to the producers of food & beverages and food supplements. But, 2′-Fucosyllactose (2’FL) segment is expected to hold the highest CAGR of XX% during the forecast period (2020-2027). Producers of dietary supplements are shifting towards 2’-fucosyllactose (2’FL) because of its capability of changing the composition and activity of gut microbiota from formula-fed infants receiving complementary feeding and its support the development of a healthy gut, which is likely to push the growth of the human milk oligosaccharides (HMO) market.

Global Human Milk Oligosaccharides (HMO) Market

To know about the Research Methodology :- Request Free Sample Report
By Application, Infant Formulas application accounted for the largest market share in 2019

Infant Formulas application accounted for the largest market share in 2019 and is expected to hold steady dominance in the forecasted period (2020-2027). This is mainly due to the growing middle-class family unit and the numerous working women are the key factors increasing the demand for human milk oligosaccharides (HMOs) in infant formulas. Likewise, the demand for human milk oligosaccharides (HMOs) in infant formulas is increasing as it encourages infant health by supporting digestive, immune, and intellectual improvement.
Global Human Milk Oligosaccharides (HMO) Market Regional Insights:

Europe is expected to account for the largest market during the forecast period in terms of value. Europe is the key region dominating the human milk oligosaccharides (HMO) market with a revenue share of 42.15% in 2019. This is mainly because of the occurrence of various prominent infant formula and baby food producers with technological advancement. The country in Europe like the UK has recorded the lowest rate for breastfeeding. This is mainly because of the increasing rate of working women population and cuts in public health funding.

Global Human Milk Oligosaccharides (HMO) Market1

Asia Pacific region is expected to be the fastest growing region with highest CAGR of XX% during the forecast period.

Asia Pacific region is expected to be the fastest-growing region with the highest CAGR of XX% during the forecast period 2020-2025. This is mainly because of the rising population, mortality rate, disposable income, and consumer alertness about health and hygiene. Growing concerns regarding gut diseases, high blood pressure, and diabetes. The developing economies such as China and India are the emerging markets for baby foods and dietary supplements.
The objective of the report is to provide the following:

• To provide market size, forecast data for global, regional and market segments
• To provide strategic developments, benchmarking and market share analysis of 10 players operating in the global human milk oligosaccharides (HMOs) market
• Detailed insights on drivers, restraints, opportunities, and challenges in the human milk oligosaccharides (HMOs) industry
• Impact of technological advancements in the human milk oligosaccharides (HMOs) market and its future outlook
• High level insights on the regional and country level analysis along with regional attractiveness
• Market intelligence on the growth trends and opportunity analysis in the human milk oligosaccharides (HMOs) market at the segmental and overall market levels

For More Information Visit :https://www.maximizemarketresearch.com/market-report/global-human-milk-oligosaccharides-hmo-market/80823/
• In-depth coverage of SWOT, PORTER, PEST and VALUE & SUPPLY CHAIN
Scope of the Global Human Milk Oligosaccharides (HMO) Market: Inquire before buying

Global Human Milk Oligosaccharides (HMO) Market, By Product

• Lacto-N-neotetraose (LNnT)
• Lacto-N-tetraose (LNT)
• 2′-Fucosyllactose (2’FL)
• 3′-Fucosyllactose (3’FL)
• 3′-Sialyllactose (3’SL)
• 6′-Sialyllactose (6’SL)
• Others
Global Human Milk Oligosaccharides (HMO) Market, By Type

• Neutral
• Acidic
Global Human Milk Oligosaccharides (HMO) Market, By Application

• Food & beverages
• Food supplements
• Infant formulas
• Others
Global Human Milk Oligosaccharides (HMO) Market, By Region

• North America
• Europe
• Asia Pacific
• Middle East & Africa
• South America
Key players operating in the Global Human Milk Oligosaccharides (HMO) Market

• Elicityl SA
• Medolac Laboratories
• Inbiose
• Glycosyn
• ZuChem
• Jennewein Biotechnologie
• Glycom
• Abbott
• BASF S.E
• Dupont De Nemours Inc
• Royal FrieslandCampina N.V
• Others

This Report Is Submitted By : Maximize Market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

SHARE NOW